Gray Sheet: CDRH Director Resigning Amidst Controversy

Courtesy of our friends at 'The Gray Sheet' we've heard that CDRH Director Daniel Schultz is leaving FDA.

Gray says that Schultz is "resigning from the agency after discussions with new FDA Commissioner Margaret Hamburg, the longtime FDA employee told staff in an Aug. 11 memo."

Schultz and the new FDA chief came to a "mutual agreement" that his resignation "would be in the best interest of the center and the agency." The decision isn't a shocker: the center--formally FDA's Center for Devices and Radiological Health--has been at the center of corruption allegations. Schultz and other FDAers have been accused of "coercing and intimidating staff into modifying device evaluations," Jessica Bylander writes for Gray. Schulz has been with FDA since 1994 and has been director at CDRH since 2004.

Read more at Gray Sheet's blog Medical Devices Today.

image from flickr user splorp used under a creative commons license.